Latest Breaking News On - Our public health solutions - Page 2 : comparemela.com

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split - Soligenix (NASDAQ:SNGX)

Most shareholders can vote by calling 1-833-782-7145 PRINCETON, N.J., May 23, 2024 /PRNewswire/ Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing

SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.

Soligenix Encourages Stockholders to Vote Prior to Annual Meeting

Annual Meeting to be held May 23, 2024 PRINCETON, N.J., May 20, 2024 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to.

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results